Ian Hodgson
CIK: 0002057525
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Corbus Pharmaceuticals Holdings, Inc.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Feb 17, 2026CRBP
Corbus Pharmaceuticals Holdings, Inc.
Sale(S)Direct847 shares at avg. $7.38$6K - Feb 3, 2026CRBP
Corbus Pharmaceuticals Holdings, Inc.
Sale(S)Direct2.4K shares at avg. $8.09$20K - Jan 14, 2026CRBP
Corbus Pharmaceuticals Holdings, Inc.
Award(A)Direct28.4K shares-
1-3 of 3 transactions
About Hodgson Ian
Hodgson Ian (SEC CIK 0002057525) files insider reports with the SEC as Chief Operating Officer of Corbus Pharmaceuticals Holdings, Inc. (CRBP).
Signal8 holds 4 ownership filings by Hodgson Ian (1 Form 3, 3 Form 4), filed between Mar 18, 2025 and Feb 18, 2026. Those filings report 3 transactions, from Jan 14, 2026 to Feb 17, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Hodgson Ian's filings is in NORWOOD, MA.
Recent filings by Hodgson Ian
Other insiders filing for Corbus Pharmaceuticals Holdings, Inc. (CRBP)
- Cormorant Asset Management, LP, Officer
- Ben Yong, Director
- Nicacio Leonardo Viana, Chief Medical Officer
- Saxena Nishant C, Chief Business Officer
- Cohen Yuval, Chief Executive Officer
- Moran Sean F., Chief Financial Officer